Berelowitz Michael 4
4 · Recro Pharma, Inc. · Filed Dec 9, 2019
Insider Transaction Report
Form 4
Berelowitz Michael
Director
Transactions
- Award
Common Stock
2019-12-05+13,848→ 41,260 total
Footnotes (1)
- [F1]These restricted stock units will vest in full on the earlier of (i) a change of control of Recro Pharma, Inc. (the "Company") (as defined in the Company's 2018 Amended and Restated Equity Incentive Plan) or (ii) December 5, 2020, subject to continued service with the Company.